Wild Birds May Play A Role In The Spread Of Bird Flu, New Research Suggests
Wild migratory birds may indeed play a role in the spread of bird flu, also known as highly pathogenic avian influenza H5N1.

Importance of Hand Sanitizer in our Everyday Life
One of the greatest advances in the history of Medicine was the discovery of microorganisms and their connection to disease. Less than 150 years ago, surgeons were performing surgery without even washing their hands. The death rate from infection was very high. Major communicable diseases were spread from person to person without any check at all. Once the connection between these little unseen killers and the havoc they create in the human body was realized, we entered a whole new era of health and longer life.

Mid-Season Flu Immunization Rates are Too Low
First of its kind survey cites misperceptions regarding need for vaccination and a lack of time as main reasons adults avoid getting immunized against influenza

China was an important breakthrough in bird flu research
Chinese scientists were the key to successful completion of the virus structural analysis will accelerate drug development process related to the Xinhua News Agency (Xinhua WU Jing-jing) press 6, learned from the CAS Institute of Biophysics, Chinese scientists in the study of the avian flu virus has made important breakthroughs: opened a virus The most important life machine - PA subunit of RNA polymerase working mechanism for the development of drugs that provide a new target

Avian Flu Economics Expert Urges Vigilance In Monitoring Recent Outbreak
The recent reoccurrence of the avian flu in China, India and the Middle East should serve as a reminder that threats to the global economy can come from a variety of sources, cautions the leader of a task force that studied the avian flu threat and its potentially devastating impact on world financial markets.

Dynavax Enters Into Supply and Option Agreement for Development of Universal Influenza Vaccine : Novartis Will Contribute Trivalent Vaccine to the C
Dynavax Technologies Corporation (Nasdaq:DVAX) today announced an agreement with Novartis Vaccines and Diagnostics, Inc. for the supply and development, and possible commercialization, of Dynavax?s novel Universal Influenza Vaccine in collaboration with Novartis. Under the agreement Novartis will provide Dynavax a supply of trivalent influenza vaccine, an essential component of Dynavax?s Universal Influenza Vaccine, for both clinical trial use and vaccine sales. Novartis receives an exclusive option to negotiate a Joint Development and Commercialization Agreement with Dynavax.